Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use APRISO safely and effectively. See full prescribing information for APRISO. APRISO™ (mesalamine) extended-release capsules Initial U.S. Approval: 1987
Medication labelWhy this: Advisory · dailymed-prescription
APRISO capsules are indicated for the maintenance of remission of ulcerative colitis in patients 18 years of age and older.
- generic_name
- mesalamine
- product_names
- mesalamine
- ndc
- 54868-6150, 65649-103, 54868-6150-0
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en